From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:1m1d.jpg|left|200px]] | + | {{Seed}} |
| | + | [[Image:1m1d.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_1m1d| PDB=1m1d | SCENE= }} | | {{STRUCTURE_1m1d| PDB=1m1d | SCENE= }} |
| | | | |
| - | '''TETRAHYMENA GCN5 WITH BOUND BISUBSTRATE ANALOG INHIBITOR'''
| + | ===TETRAHYMENA GCN5 WITH BOUND BISUBSTRATE ANALOG INHIBITOR=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Histone acetyltransferases (HATs) use acetyl CoA to acetylate target lysine residues within histones and other transcription factors, such as the p53 tumor suppressor, to promote gene activation. HAT enzymes fall into subfamilies with divergence in sequence and substrate preference. Several HAT proteins have been implicated in human cancer. We have previously reported on the preparation of peptide-CoA conjugate inhibitors with distinct specificities for the p300/CBP [cAMP response element binding protein (CREB)-binding protein] or GCN5 HAT subfamilies. Here we report on the crystal structure of the GCN5 HAT bound to a peptide-CoA conjugate containing CoA covalently attached through an isopropionyl linker to Lys-14 of a 20-aa N-terminal fragment of histone H3. Surprisingly, the structure reveals that the H3 portion of the inhibitor is bound outside of the binding site for the histone substrate and that only five of the 20 aa residues of the inhibitor are ordered. Rearrangements within the C-terminal region of the GCN5 protein appear to mediate this peptide displacement. Mutational and enzymatic data support the hypothesis that the observed structure corresponds to a late catalytic intermediate. The structure also provides a structural scaffold for the design of HAT-specific inhibitors that may have therapeutic applications for the treatment of HAT-mediated cancers.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_12391296}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 12391296 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_12391296}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 31: |
Line 35: |
| | [[Category: Inhibitor complex]] | | [[Category: Inhibitor complex]] |
| | [[Category: Transcription factor]] | | [[Category: Transcription factor]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 00:30:58 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 23:00:30 2008'' |
Revision as of 20:00, 2 July 2008
Template:STRUCTURE 1m1d
TETRAHYMENA GCN5 WITH BOUND BISUBSTRATE ANALOG INHIBITOR
Template:ABSTRACT PUBMED 12391296
About this Structure
1M1D is a Protein complex structure of sequences from Tetrahymena thermophila. Full crystallographic information is available from OCA.
Reference
Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor., Poux AN, Cebrat M, Kim CM, Cole PA, Marmorstein R, Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14065-70. Epub 2002 Oct 21. PMID:12391296
Page seeded by OCA on Wed Jul 2 23:00:30 2008
